Reportstack, provider of premium market research reports announces the addition of US Colorectal Cancer Drug Pipeline Analysis market report to its offering
Among all the regions affected with colorectal cancer, the US would continue to account for a giants share owing to its huge population base. With regards to rates of increase, it is most likely that the US would witness a modest increase in the prevalence of the disease, mostly as a result of the country having already reached epidemic proportions of the disease. According to estimates, approximately 55,000 people die of this type of cancer in the US every year. In 2013, close to 142,820 people new cases are estimated to be diagnosed with colorectal cancer, including 102,480 case of colon cancer and 40,340 cases of rectal cancer.